PACB supply chain intelligence for Pacific Biosciences of California, Inc.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.
Data compiled by Redley Lamar · ChainSifter Intelligence
Pacific Biosciences of California, Inc. (PACB) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| INSTRUMENTS | INSTRUMENTS | 90% | We have chosen to source certain products and critical components from a single source, including suppliers for our SMRT Cells, reagents, and instruments. |
| REAGENTS | REAGENTS | 90% | We have chosen to source certain products and critical components from a single source, including suppliers for our SMRT Cells, reagents, and instruments. |
| SMRT-CELLS | SMRT-CELLS | 90% | We have chosen to source certain products and critical components from a single source, including suppliers for our SMRT Cells, reagents, and instruments. |
| BNGO | Bionano Genomics, Inc. | 72% | Reciprocal relationship from BNGO graph: Reciprocal relationship from PACB graph: We manufacture sequencing instruments, SMRT Cells, and reagents. Our key manufacturing and service facility in Menlo … |
| BNGO | Bionano Genomics, Inc. | 72% | We manufacture sequencing instruments, SMRT Cells, and reagents. Our key manufacturing and service facility in Menlo Park, California has received ISO 13485 and ISO 9001 certifications for the design… |
| GH | Guardant Health, Inc. | 72% | Reciprocal relationship from GH graph: r therapy selection, that sell molecular diagnostic tests for cancer to physicians and have or may develop tests that compete with our tests. In addition, we ar… |
| QGEN | Qiagen N.V. | 72% | We manufacture sequencing instruments, SMRT Cells, and reagents. Our key manufacturing and service facility in Menlo Park, California has received ISO 13485 and ISO 9001 certifications for the design… |
| QGEN | Qiagen N.V. | 72% | Reciprocal relationship from QGEN graph: Reciprocal relationship from PACB graph: We manufacture sequencing instruments, SMRT Cells, and reagents. Our key manufacturing and service facility in Menlo … |
| SQLLW | SQLLW | 72% | Reciprocal relationship from SQLLW graph: Reciprocal relationship from PACB graph: Reciprocal relationship from SQLLW graph: solution’s value proposition marketing material. ● Implementing new custom… |
| TMO | Thermo Fisher Scientific Inc. | 72% | We manufacture sequencing instruments, SMRT Cells, and reagents. Our key manufacturing and service facility in Menlo Park, California has received ISO 13485 and ISO 9001 certifications for the design… |
| TMO | Thermo Fisher Scientific Inc. | 72% | Reciprocal relationship from TMO graph: Reciprocal relationship from PACB graph: We manufacture sequencing instruments, SMRT Cells, and reagents. Our key manufacturing and service facility in Menlo P… |
| TXG | 10x Genomics, Inc. | 72% | Reciprocal relationship from TXG graph: Reciprocal relationship from PACB graph: Reciprocal relationship from TXG graph: Reciprocal relationship from PACB graph: We manufacture sequencing instruments… |
| TXG | 10x Genomics, Inc. | 72% | We manufacture sequencing instruments, SMRT Cells, and reagents. Our key manufacturing and service facility in Menlo Park, California has received ISO 13485 and ISO 9001 certifications for the design… |
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| BNGO | Bionano Genomics, Inc. | 72% | Reciprocal relationship from BNGO graph: Reciprocal relationship from PACB graph: We manufacture sequencing instruments, SMRT Cells, and reagents. Our key manufacturing and service facility in Menlo … |
| BNGO | Bionano Genomics, Inc. | 72% | We manufacture sequencing instruments, SMRT Cells, and reagents. Our key manufacturing and service facility in Menlo Park, California has received ISO 13485 and ISO 9001 certifications for the design… |
| GH | Guardant Health, Inc. | 72% | Reciprocal relationship from GH graph: Reciprocal relationship from PACB graph: Reciprocal relationship from GH graph: r therapy selection, that sell molecular diagnostic tests for cancer to physicia… |
| QGEN | Qiagen N.V. | 72% | Reciprocal relationship from QGEN graph: Reciprocal relationship from PACB graph: Reciprocal relationship from QGEN graph: Reciprocal relationship from PACB graph: Reciprocal relationship from QGEN g… |
| QGEN | Qiagen N.V. | 72% | We manufacture sequencing instruments, SMRT Cells, and reagents. Our key manufacturing and service facility in Menlo Park, California has received ISO 13485 and ISO 9001 certifications for the design… |
| SQLLW | SQLLW | 72% | Reciprocal relationship from SQLLW graph: solution’s value proposition marketing material. ● Implementing new customer facing programs including trade show participation, posters and presentations to… |
| TMO | Thermo Fisher Scientific Inc. | 72% | Reciprocal relationship from TMO graph: Reciprocal relationship from PACB graph: Reciprocal relationship from TMO graph: Reciprocal relationship from PACB graph: We manufacture sequencing instruments… |
| TMO | Thermo Fisher Scientific Inc. | 72% | We manufacture sequencing instruments, SMRT Cells, and reagents. Our key manufacturing and service facility in Menlo Park, California has received ISO 13485 and ISO 9001 certifications for the design… |
| TXG | 10x Genomics, Inc. | 72% | Reciprocal relationship from TXG graph: Reciprocal relationship from PACB graph: We manufacture sequencing instruments, SMRT Cells, and reagents. Our key manufacturing and service facility in Menlo P… |
| TXG | 10x Genomics, Inc. | 72% | We manufacture sequencing instruments, SMRT Cells, and reagents. Our key manufacturing and service facility in Menlo Park, California has received ISO 13485 and ISO 9001 certifications for the design… |
| CAPITAL-RESOURCES | CAPITAL-RESOURCES | 62% | n Form 10-K, pursuant to Instruction 2 to paragraph (b) of Item 303 of Regulation S-K. Our MD&A is organized into the following sections: • Overview and Outlook • Results of Operations • Liquidity an… |
| COMPLETE-GENOMICS-THERMO-ONT-LTD | COMPLETE-GENOMICS-THERMO-ONT-LTD | 62% | materially and adversely impact our business. We operate in a highly competitive industry and if we are not able to compete effectively, our business and operating results will likely be harmed. Ther… |
| ILLUMINA-CAMBRIDGE-LIMITED | ILLUMINA-CAMBRIDGE-LIMITED | 62% | llion in instrument revenue, $21.8 million in consumables revenue and $5.6 million in service and other revenue during the three months ended March 31, 2026. Revenue was comprised of $11.0 million in… |
| ILMN | Illumina, Inc. | 62% | Reciprocal relationship from ILMN graph: Reciprocal relationship from PACB graph: Reciprocal relationship from ILMN graph: Reciprocal relationship from PACB graph: Reciprocal relationship from ILMN g… |
| MANNHEIM-GERMANY-ONT-LTD | MANNHEIM-GERMANY-ONT-LTD | 62% | strict of Delaware and, previously, with the U.S. International Trade Commission, in the High Court of England and Wales and in the District Court of Mannheim, Germany. ONT Ltd. previously filed clai… |
| ONT-LTD | ONT-LTD | 62% | tially competing technologies, products and/or services, including ONT Ltd. and its subsidiaries, against whom we have filed complaints for patent infringement in the U.S. District Court for the Dist… |
| U-S-BANK-TRUST-COMPANY | U-S-BANK-TRUST-COMPANY | 62% | e). On the 361 st day after such event of default (if the event of default relating to our failure to comply with its obligations is not cured or waived prior to such 361 st day), the 2029 Notes shal… |
| Instrument | Description | Confidence | Evidence |
|---|---|---|---|
| PACB-DEBT | Debt stack $13.5M | 90% | Market cache reports total debt of $13.5M. |
| PACB-DEBT-11647 | Warrants outstanding: 4200000 | 90% | xbrl warrant detail from xbrl 2016-12-31. |
| PACB-DEBT-11648 | Xbrl Convertible | 90% | xbrl convertible detail from xbrl 2026-03-31. |
| Holder | Name | Confidence | Evidence |
|---|---|---|---|
| PACB-OWNER-ARK-INVESTMENT-MANAGEMENT-LLC | ARK Investment Management LLC | 90% | 13F overlay lists ARK Investment Management LLC as top holder; 235 tracked holders. |
| Ticker | Name | Chain Index | Hops | Relationship Types |
|---|---|---|---|---|
| TMO | Thermo Fisher Scientific Inc. | 100.00 | 1 | ['customer', 'supplier'] |
| GH | Guardant Health, Inc. | 100.00 | 1 | ['customer', 'supplier'] |
| MYGN | Myriad Genetics, Inc. | 100.00 | 2 | |
| TXG | 10x Genomics, Inc. | 100.00 | 1 | ['customer', 'supplier'] |
| EXAS | Exact Sciences Corp | 100.00 | 2 | |
| BNGO | Bionano Genomics, Inc. | 100.00 | 1 | ['customer', 'supplier'] |
| ILMN | Illumina, Inc. | 100.00 | 1 | ['customer'] |
| TEM | Tempus AI, Inc. | 100.00 | 2 | |
| QGEN | Qiagen N.V. | 100.00 | 1 | ['customer', 'supplier'] |
| YDES | YD Bio Ltd | 100.00 | 2 | |
| GRAL | GRAIL, Inc. | 100.00 | 2 | |
| SQLLW | ATLANTIC INTERNATIONAL CORP. | 100.00 | 1 | ['customer', 'supplier'] |
| PSNL | Personalis, Inc. | 100.00 | 2 | |
| SOPH | SOPHiA GENETICS SA | 50.00 | 2 | |
| ICLR | ICON Public Limited Company | 50.00 | 2 | |
| ATLN | Atlantic International Corp. | 50.00 | 2 | |
| FLGT | Fulgent Genetics, Inc. | 50.00 | 2 | |
| BIO | Bio-Rad Laboratories, Inc. | 50.00 | 2 | |
| CLWT | Euro Tech Holdings Company Limited | 50.00 | 2 | |
| CLLS | Cellectis S.A. | 50.00 | 2 |